0 items USD 0.00Search
Your search for "globaldata grandtech cg systems inc 6123 financial strategic swot analysis review 0" gave back 217591 results.
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...
Catalog:
Global Markets Direct
May 2022
Price: USD 3,500.00
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Gamma Isoform - Pipeline Review, H1 2020 Summary Phosphatidylinositol 4,5...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Neuropeptide Y Receptor Type 2 - Pipeline Review, H2 2020 Summary Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) pipeline Target...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021 Summary According to the recently published report '...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Neuropeptide Y Receptor Type 2 - Pipeline Review, H1 2020 Summary Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Neuropeptide Y receptor...
Catalog:
Global Markets Direct
March 2020
Price: USD 3,500.00
Neuropeptide Y Receptor Type 2 - Pipeline Review, H2 2019 Summary Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Neuropeptide Y receptor...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Gamma Isoform - Pipeline Review, H2 2019 Summary According to the recently published...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Pipeline Review, H1 2018 Summary According to the recently published report '...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018 Summary Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4)...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Community Health Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Community Health Systems, Inc. - Strategy, SWOT and Corporate...
MarketLine
November 2022
Price: USD 175.00
Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate...
MarketLine
November 2022
Price: USD 175.00
Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc - Strategy, SWOT and Corporate Finance Report...
MarketLine
February 2022
Price: USD 175.00
Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
November 2022
Price: USD 175.00
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
January 2023
Price: USD 175.00
